Agentix (AGTX) Cash & Equivalents (2013 - 2026)
Agentix (AGTX) recorded Cash & Equivalents of $38.00 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 99.1% from $4,412 a year earlier and down 95.1% from the prior quarter.
Powered by 
Analysis
Agentix (AGTX) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Agentix reported Cash & Equivalents of $771.00, down 82.8% from FY2025.
- Annual Cash & Equivalents has declined for three straight fiscal years, with a five-year compound annual growth rate of -15.3% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $4,477 in FY2025 (-31.5%), $6,535 in FY2024 (-47.2%), $12,369 in FY2023 and $145.00 in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Cash & Equivalents in data going back to fiscal Q1 2023.
- On a year-over-year basis, Cash & Equivalents has declined for six consecutive quarters, with an average decline of 29.8% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 919.2% in fiscal Q2 2024, against a decline of 99.1% in fiscal Q1 2027 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $771.00 (Q4 2026), $6,396 (Q3 2026) and $5,601 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Agentix | 801,339.00 | 788,533.00 | - | 38.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.00 |
| Mar 31, 2026 | 771.00 |
| Dec 31, 2025 | 6,396.00 |
| Sep 30, 2025 | 5,601.00 |
| Jun 30, 2025 | 4,412.00 |
| Mar 31, 2025 | 4,477.00 |
| Dec 31, 2024 | 8,273.00 |
| Sep 30, 2024 | 6,345.00 |
| Jun 30, 2024 | 9,072.00 |
| Mar 31, 2024 | 6,535.00 |
| Dec 31, 2023 | 3,480.00 |
| Sep 30, 2023 | 27,538.00 |
| Jun 30, 2023 | 5,856.00 |
| Mar 31, 2023 | 12,369.00 |
| Dec 31, 2022 | 679.00 |
| Sep 30, 2022 | 2,702.00 |
| Jun 30, 2022 | 189.00 |
| Feb 28, 2022 | 2,442.00 |
| Nov 30, 2021 | 1,237.00 |
| Aug 31, 2021 | 1,768.00 |
API Access
Agentix Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();